# Ubiquitin conjugation cascade

The ubiquitin conjugation cascade is the ATP-dependent, three-enzyme pathway (E1, E2, and E3) that attaches the 76-amino-acid protein ubiquitin to substrate proteins inside cells, usually through an isopeptide bond between ubiquitin's C-terminal glycine and a substrate lysine.<sup>[1](https://www.ncbi.nlm.nih.gov/sites/books/NBK556052/)</sup> [Ubiquitination](https://www.edgepedia.org/ubiquitination) regulates protein function or targets proteins for degradation, and defects in ubiquitin-mediated proteolysis have a causal role in many human diseases, including a variety of cancers.<sup>[2](https://www.nobelprize.org/uploads/2018/06/advanced-chemistryprize2004-1.pdf)</sup><sup> • </sup><sup>[3](https://www.reactome.org/content/detail/R-HSA-8852135)</sup> Its components have been described as potential therapeutic targets.<sup>[4](https://www.mdpi.com/2227-9059/14/5/1070)</sup>

| Key fact | Value | Meaning |
|---|---|---|
| Human enzyme counts | 2 E1s (UBA1, UBA6), ~40 E2s, over 600 E3s<sup>[5](https://www.frontiersin.org/journals/physiology/articles/10.3389/fphys.2019.00835/full)</sup> | A small activation layer feeds a huge specificity layer |
| Where ATP is spent | E1 forms a C-terminal ubiquitin–AMP (acyl adenylate) before thioester transfer<sup>[6](https://doi.org/10.1002/cbic.202400659)</sup> | E1 activation is the ATP-dependent step of the cascade |
| Ubiquitin pool in a HeLa cell | ~4.5 × 10⁷ ubiquitin molecules, ~80% conjugated<sup>[7](https://pmc.ncbi.nlm.nih.gov/articles/PMC11136510/)</sup> | Most cellular ubiquitin is in use at any moment |
| Ubiquitylation sites | ~100,000 sites in mammalian cells<sup>[7](https://pmc.ncbi.nlm.nih.gov/articles/PMC11136510/)</sup> | Median site occupancy is only ~0.008%<sup>[7](https://pmc.ncbi.nlm.nih.gov/articles/PMC11136510/)</sup> |
| Chain code | Eight linkage sites (M1 plus seven lysines); K48 targets the proteasome, K63 scaffolds DNA repair, and signaling<sup>[8](https://link.springer.com/article/10.1186/s13578-022-00870-y)</sup><sup> • </sup><sup>[1](https://www.ncbi.nlm.nih.gov/sites/books/NBK556052/)</sup> | Chain topology encodes different outcomes |
| Recognition award | 2004 Nobel Prize in Chemistry to Ciechanover, Hershko, and Rose<sup>[2](https://www.nobelprize.org/uploads/2018/06/advanced-chemistryprize2004-1.pdf)</sup> | |

## Discovery and historical arc

Before the 1980s, most intracellular proteins were believed to be long-lived, an assumption that persisted despite contrary evidence from Schoenheimer in 1942.<sup>[9](https://www.annualreviews.org/content/journals/10.1146/annurev-biochem-061516-044859)</sup> In the 1950s and 1960s, protein degradation received little research attention because work on protein synthesis dominated the field.<sup>[10](https://www.nature.com/articles/4401702)</sup>

The reticulocyte experiments changed that. Between 1978 and 1980, [Avram Hershko](https://www.edgepedia.org/avram-hershko) and coworkers showed that proteins added to a mammalian cell extract became covalently conjugated to a small, 76-residue protein termed ubiquitin, and that ubiquitylated proteins were destroyed by an ATP-dependent protease.<sup>[9](https://www.annualreviews.org/content/journals/10.1146/annurev-biochem-061516-044859)</sup> In 1981–1983 the same group identified the three enzyme types, E1, E2, and E3, that mediate ubiquitin conjugation.<sup>[9](https://www.annualreviews.org/content/journals/10.1146/annurev-biochem-061516-044859)</sup><sup> • </sup><sup>[10](https://www.nature.com/articles/4401702)</sup> Retrospective analysis of the original reticulocyte fractionation suggests that multiple ligases were already active in fraction II, which may explain why so many different proteins were ubiquitinated in those assays.<sup>[11](https://www.pnas.org/doi/10.1073/pnas.0504842102)</sup> In 1990, [Alexander Varshavsky](https://www.edgepedia.org/alexander-varshavsky)'s laboratory at Caltech identified and cloned Ubr1, the first molecularly cloned E3 ubiquitin ligase.<sup>[9](https://www.annualreviews.org/content/journals/10.1146/annurev-biochem-061516-044859)</sup> The 2004 [Nobel Prize in Chemistry](https://www.edgepedia.org/nobel-prize-in-chemistry) was awarded to Aaron Ciechanover, Avram Hershko, and Irwin Rose for the discovery of ubiquitin-mediated proteolysis.<sup>[2](https://www.nobelprize.org/uploads/2018/06/advanced-chemistryprize2004-1.pdf)</sup>

## The chemistry of ubiquitin attachment

Ubiquitin is a small, 76-amino-acid protein. Conjugation begins when an E1 enzyme activates ubiquitin in an ATP-dependent manner, forming a C-terminal acyl adenylate (ubiquitin–AMP); the activated ubiquitin is then transferred to a catalytic cysteine on E1, creating a thioester bond.<sup>[1](https://www.ncbi.nlm.nih.gov/sites/books/NBK556052/)</sup><sup> • </sup><sup>[6](https://doi.org/10.1002/cbic.202400659)</sup><sup> • </sup><sup>[12](https://doi.org/10.1042/bj20040198)</sup> Full activity requires E1 to bind and adenylate a second ubiquitin non-covalently while the first is thioester-linked, so E1 holds two ubiquitins at once.<sup>[12](https://doi.org/10.1042/bj20040198)</sup>

From E1, ubiquitin passes by transesterification to the active-site cysteine of an E2 conjugating enzyme, again as a thioester.<sup>[1](https://www.ncbi.nlm.nih.gov/sites/books/NBK556052/)</sup><sup> • </sup><sup>[13](https://www.annualreviews.org/content/journals/10.1146/annurev-biochem-060815-014922)</sup> The E3 ligase then catalyses transfer from E2-bound ubiquitin to the substrate, usually forming an isopeptide bond between ubiquitin's C-terminal glycine and a substrate lysine.<sup>[1](https://www.ncbi.nlm.nih.gov/sites/books/NBK556052/)</sup><sup> • </sup><sup>[2](https://www.nobelprize.org/uploads/2018/06/advanced-chemistryprize2004-1.pdf)</sup> [Iteration](https://www.edgepedia.org/iteration) of this reaction yields polyubiquitin chains.<sup>[2](https://www.nobelprize.org/uploads/2018/06/advanced-chemistryprize2004-1.pdf)</sup>

**Atypical linkages exist.** Cysteine, serine, and threonine linkages have been observed alongside lysine conjugation,<sup>[3](https://www.reactome.org/content/detail/R-HSA-8852135)</sup> ubiquitylation can rarely occur on the [N-terminus](https://www.edgepedia.org/n-terminus) of a substrate protein,<sup>[12](https://doi.org/10.1042/bj20040198)</sup> and recent years have identified ester-bond linkages and even non-protein substrates such as lipids, sugars, and nucleotides.<sup>[6](https://doi.org/10.1002/cbic.202400659)</sup>

## The E1–E2–E3 cascade step by step

Each enzyme has a distinct role. E1 activates ubiquitin and hands it to E2; E2 is the ubiquitin carrier whose cysteine forms the thioester;<sup>[13](https://www.annualreviews.org/content/journals/10.1146/annurev-biochem-060815-014922)</sup> E3 binds both the charged E2 and the substrate and catalyses the final transfer.<sup>[1](https://www.ncbi.nlm.nih.gov/sites/books/NBK556052/)</sup>

**Why three enzymes?** The answer is specificity through division of labor. E3s recognize and bind specific substrate sequences called degrons, and the E3 is usually the only cascade component subject to regulation.<sup>[12](https://doi.org/10.1042/bj20040198)</sup> Humans have two ubiquitin-selective E1s: [UBA1](https://www.edgepedia.org/uba1), which transfers to a wide array of E2s, and UBA6, which is an order of magnitude less abundant and loads ubiquitin specifically onto the E2 UBE2Z (USE1).<sup>[5](https://www.frontiersin.org/journals/physiology/articles/10.3389/fphys.2019.00835/full)</sup>

Family-level detail, such as the structures and regulation of individual E1, E2, and E3 classes, is covered in the sibling articles on E1, E2, and the E3 ligase families; this overview treats only the shared cascade logic.

## By the numbers

The combinatorial structure of the system is striking. The human genome encodes two E1s,<sup>[5](https://www.frontiersin.org/journals/physiology/articles/10.3389/fphys.2019.00835/full)</sup> roughly 40 E2s dedicated to ubiquitin conjugation,<sup>[5](https://www.frontiersin.org/journals/physiology/articles/10.3389/fphys.2019.00835/full)</sup> and over 600 E3s,<sup>[5](https://www.frontiersin.org/journals/physiology/articles/10.3389/fphys.2019.00835/full)</sup> with proteins responsible for ubiquitination encoded by about 5% of the human genome.<sup>[5](https://www.frontiersin.org/journals/physiology/articles/10.3389/fphys.2019.00835/full)</sup> Other counts circulate: StatPearls cites almost 700 E3s,<sup>[1](https://www.ncbi.nlm.nih.gov/sites/books/NBK556052/)</sup> a Cell & Bioscience review cites more than 1000 E3s,<sup>[8](https://link.springer.com/article/10.1186/s13578-022-00870-y)</sup> and Varshavsky's review estimates about 1,000 distinct E3s in the mammalian genome.<sup>[9](https://www.annualreviews.org/content/journals/10.1146/annurev-biochem-061516-044859)</sup> A human proteome analysis identified approximately 580 putative RING-type E3 genes alone, more than the 518 protein kinase genes.<sup>[14](https://doi.org/10.5772/intechopen.100408)</sup>

At the cellular scale, a HeLa cell contains roughly 4 × 10⁹ protein molecules, and ubiquitin constitutes about 1.1% of them, about 4.5 × 10⁷ ubiquitin molecules, of which roughly 80% are conjugated to proteins at steady state.<sup>[7](https://pmc.ncbi.nlm.nih.gov/articles/PMC11136510/)</sup> Mammalian cells carry ubiquitylation at about 100,000 sites, controlled by approximately 640 ubiquitylating enzymes and around 90 deubiquitylases.<sup>[7](https://pmc.ncbi.nlm.nih.gov/articles/PMC11136510/)</sup> Despite that abundance, the median occupancy of an individual ubiquitylation site is only about 0.008% (measured 0.0081%, matching a theoretical estimate of 0.0085%), reflecting low abundance and fast turnover of individual modification events.<sup>[7](https://pmc.ncbi.nlm.nih.gov/articles/PMC11136510/)</sup>

## RING versus HECT versus RBR: catalytic strategies compared

E3 ligases fall into mechanistic classes that differ in a single decisive respect: whether the E3 itself ever holds ubiquitin.

**RING ligases are scaffolds.** RING E3s do not form thioester intermediates with ubiquitin; they bind the substrate and the E2~ubiquitin conjugate simultaneously and prime the complex for transfer by promoting a closed E2~ubiquitin conformation in which the thioester is activated toward nucleophilic attack by the substrate lysine.<sup>[15](https://www.nature.com/articles/nrm.2016.91)</sup><sup> • </sup><sup>[14](https://doi.org/10.5772/intechopen.100408)</sup> RING-type E3s include single-subunit enzymes such as the Cbl family and multi-subunit assemblies such as Cullin-RING ligases.<sup>[1](https://www.ncbi.nlm.nih.gov/sites/books/NBK556052/)</sup>

**HECT and RBR ligases take possession of ubiquitin.** Both proceed through a two-step mechanism in which ubiquitin is first transferred from the E2 to the active-site cysteine of the E3, forming an E3~ubiquitin thioester, before conjugation to the substrate.<sup>[5](https://www.frontiersin.org/journals/physiology/articles/10.3389/fphys.2019.00835/full)</sup> In HECT E3s, conformational changes juxtapose the catalytic cysteines of E2 and E3 and then the E3 cysteine with the substrate residue.<sup>[15](https://www.nature.com/articles/nrm.2016.91)</sup> Humans have 14 RBR E3s, including PARKIN, HHARI, and HOIP; in 2011 a conserved catalytic cysteine in the RING2 domain of HHARI and PARKIN was shown to form a ubiquitin thioester, redefining the RBR mechanism as a hybrid of RING and HECT. RBR E3s are autoinhibited in solution and require relief of autoinhibition before transfer.<sup>[15](https://www.nature.com/articles/nrm.2016.91)</sup>

**The classification is still expanding.** A 2026 review classifies E3s into four major families, RING, HECT, RBR, and RCR, and notes that E4 chain-elongation ligases can extend ubiquitin chains already attached to a target protein.<sup>[16](https://www.frontiersin.org/journals/molecular-biosciences/articles/10.3389/fmolb.2026.1745654/full)</sup> For some RING E3s, one E2 monoubiquitylates the substrate and a second E2 performs chain elongation.<sup>[15](https://www.nature.com/articles/nrm.2016.91)</sup>

## Chain architectures and physiological roles

Ubiquitin contains one N-terminal methionine (M1) and seven lysine residues (K6, K11, K27, K29, K33, K48, K63), giving eight free amino groups that serve as linkage sites for mono-, multi-mono- and polyubiquitin chains, including homotypic, mixed, and branched architectures.<sup>[8](https://link.springer.com/article/10.1186/s13578-022-00870-y)</sup> Chain topology is a code. K48-linked chains, the most abundant cellular linkage, target substrate proteins to the 26S proteasome for degradation.<sup>[8](https://link.springer.com/article/10.1186/s13578-022-00870-y)</sup><sup> • </sup><sup>[1](https://www.ncbi.nlm.nih.gov/sites/books/NBK556052/)</sup> K63-linked chains generally act as scaffolds recruiting other proteins in processes including [DNA repair](https://www.edgepedia.org/dna-repair), signal transduction, and endocytosis, without targeting for degradation.<sup>[1](https://www.ncbi.nlm.nih.gov/sites/books/NBK556052/)</sup><sup> • </sup><sup>[3](https://www.reactome.org/content/detail/R-HSA-8852135)</sup> K11-linked chains appear in endoplasmic reticulum-associated degradation (ERAD), and K29-linked chains in lysosomal degradation.<sup>[3](https://www.reactome.org/content/detail/R-HSA-8852135)</sup> Structurally, K63-linked di-ubiquitin adopts a more extended conformation than K48-linked di-ubiquitin, consistent with its scaffolding rather than degradative role.<sup>[12](https://doi.org/10.1042/bj20040198)</sup>

**Which arm does what.** Monoubiquitylation of receptor tyrosine kinases and other plasma membrane proteins recruits endocytic proteins and signals receptor endocytosis and lysosomal targeting.<sup>[12](https://doi.org/10.1042/bj20040198)</sup> Some E3–E2 combinations catalyze monoubiquitination while others build polyubiquitin chains.<sup>[3](https://www.reactome.org/content/detail/R-HSA-8852135)</sup> Substrate lysine selection depends on the spatial arrangement within E2–E3–substrate complexes, with lysines proximal to the E2 or E3 active sites prioritized for ligation.<sup>[15](https://www.nature.com/articles/nrm.2016.91)</sup>

## References

1. [Biochemistry, Ubiquitination — StatPearls (NCBI Bookshelf)](https://www.ncbi.nlm.nih.gov/sites/books/NBK556052/)
2. [Ubiquitin-mediated proteolysis — Nobel Prize in Chemistry 2004 (advanced information)](https://www.nobelprize.org/uploads/2018/06/advanced-chemistryprize2004-1.pdf)
3. [Reactome | Protein ubiquitination](https://www.reactome.org/content/detail/R-HSA-8852135)
4. [Ubiquitylation and Deubiquitylation in Health and Diseases (Biomolecules)](https://www.mdpi.com/2227-9059/14/5/1070)
5. [Enzymatic Logic of Ubiquitin Chain Assembly (Frontiers in Physiology)](https://www.frontiersin.org/journals/physiology/articles/10.3389/fphys.2019.00835/full)
6. [Chemical Tools for Probing the Ub/Ubl Conjugation Cascades (ChemBioChem, 2024)](https://doi.org/10.1002/cbic.202400659)
7. [Global, site-resolved analysis of ubiquitylation occupancy and turnover rate reveals systems properties](https://pmc.ncbi.nlm.nih.gov/articles/PMC11136510/)
8. [Current methodologies in protein ubiquitination characterization (Cell & Bioscience)](https://link.springer.com/article/10.1186/s13578-022-00870-y)
9. [The Ubiquitin System, Autophagy, and Regulated Protein Degradation (Annual Review of Biochemistry, Varshavsky)](https://www.annualreviews.org/content/journals/10.1146/annurev-biochem-061516-044859)
10. [The ubiquitin system for protein degradation and some of its roles in the control of the cell division cycle (Ciechanover)](https://www.nature.com/articles/4401702)
11. [The discovery of ubiquitin-dependent proteolysis (PNAS)](https://www.pnas.org/doi/10.1073/pnas.0504842102)
12. [Getting into position: the catalytic mechanisms of protein ubiquitylation (Biochemical Journal)](https://doi.org/10.1042/bj20040198)
13. [Ubiquitin Ligases: Structure, Function, and Regulation (Annual Review of Biochemistry)](https://www.annualreviews.org/content/journals/10.1146/annurev-biochem-060815-014922)
14. [Ubiquitination Enzymes (IntechOpen book chapter)](https://doi.org/10.5772/intechopen.100408)
15. [Structural insights into the catalysis and regulation of E3 ubiquitin ligases (Nature Reviews Molecular Cell Biology)](https://www.nature.com/articles/nrm.2016.91)
16. [E3 ubiquitin ligases: structural diversity, dysregulation in disease, and their emerging role in targeted therapeutic strategies (Frontiers in Molecular Biosciences)](https://www.frontiersin.org/journals/molecular-biosciences/articles/10.3389/fmolb.2026.1745654/full)

---
*Topic: Encyclopedia › Life and health › Biological foundations › Biochemistry and metabolism › Enzyme classes and activities › Ubiquitination and protein-modification enzymes › Ubiquitin conjugation machinery › Ubiquitin conjugation overview*

*Initially written Sep 17, 2026 · Edited: Oct 11, 2026; Oct 15, 2026*

*Copyright 2026 EdgeChat AI, a subsidiary of Biostate AI.*

License: Edgepedia Community License 1.0, https://www.edgepedia.org/edgepedia/license
